{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diffuse+Scleroderma&page=11", "query": { "condition": "Diffuse Scleroderma", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 260, "total_pages": 26, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diffuse+Scleroderma&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diffuse+Scleroderma&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T15:29:09.252Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00512902", "title": "A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alveolitis", "Systemic Sclerosis" ], "interventions": [ { "name": "Imatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2007-08", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2014-10-27", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00512902" }, { "nct_id": "NCT01445821", "title": "Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Scleroderma, Systemic" ], "interventions": [ { "name": "Peripheral Blood Stem Cells", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "rATG", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "17 Years to 60 Years" }, "enrollment_count": 44, "start_date": "2011-09-15", "completion_date": "2019-10-10", "has_results": true, "last_update_posted_date": "2020-07-23", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01445821" }, { "nct_id": "NCT01111786", "title": "Finger Hardness Measure in Scleroderma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Scleroderma" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2010-04", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2014-06-26", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01111786" }, { "nct_id": "NCT01729611", "title": "Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Hypertension" ], "interventions": [], "intervention_types": [], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "17 Years to 90 Years" }, "enrollment_count": 119, "start_date": "2013-12", "completion_date": "2021-04", "has_results": false, "last_update_posted_date": "2021-04-02", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01729611" }, { "nct_id": "NCT03919799", "title": "KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "System; Sclerosis", "Diffuse Cutaneous Systemic Sclerosis" ], "interventions": [ { "name": "Belumosudil (KD025)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kadmon, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 36, "start_date": "2019-06-26", "completion_date": "2023-02-17", "has_results": true, "last_update_posted_date": "2023-08-30", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03919799" }, { "nct_id": "NCT00934427", "title": "Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Raynaud Disease" ], "interventions": [ { "name": "0.9% nitroglycerin in TAM cream", "type": "DRUG" }, { "name": "vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediQuest Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 100, "start_date": "2009-06", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-07-20", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 11, "location_summary": "Redwood City, California • Farmington, Connecticut • Boston, Massachusetts + 8 more", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00934427" }, { "nct_id": "NCT00442611", "title": "A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Scleroderma, Diffuse", "Scleroderma, Systemic" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2008-11", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2017-10-31", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00442611" }, { "nct_id": "NCT07047690", "title": "A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Sclerosis" ], "interventions": [ { "name": "Nemolizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 162, "start_date": "2026-02-20", "completion_date": "2028-07-23", "has_results": false, "last_update_posted_date": "2026-03-31", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan • Arlington, Texas", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07047690" }, { "nct_id": "NCT06338722", "title": "Making it Work Program for Systemic Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Scleroderma, Systemic" ], "interventions": [ { "name": "Making it Work Systemic Sclerosis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "67 Years", "sex": "ALL", "summary": "18 Years to 67 Years" }, "enrollment_count": 33, "start_date": "2023-12-08", "completion_date": "2025-01-22", "has_results": false, "last_update_posted_date": "2025-02-13", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT06338722" }, { "nct_id": "NCT00522002", "title": "CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Connective Tissue Diseases", "Blood Coagulation Disorders", "Leg Ulcers", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Systemic Scleroderma", "Mixed Connective Tissue Disease" ], "interventions": [], "intervention_types": [], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2007-08", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2017-08-30", "last_synced_at": "2026-10-22T15:29:09.252Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00522002" } ] }